Evidence for safety margins of lignocaine local anaesthetics for peri-oral use

British Dental Journal

Volumn 181, Issue 7, 1996, Pages 243-249

  Cannell, H ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ADULT; BLOOD; BODY WEIGHT; CHILD; DENTAL ANESTHESIA; DENTAL CARE; HUMAN; INJECTION; REVIEW; STANDARD;

ADULT; ANESTHESIA, DENTAL; ANESTHETICS, LOCAL; BODY WEIGHT; CHILD; DENTAL CARE FOR CHRONICALLY ILL; EPINEPHRINE; HUMANS; INJECTIONS; LIDOCAINE; REFERENCE STANDARDS;

EID: 0030571142     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4809223     Document Type: Article

References (44)

1. ABPI data sheet compendium 1995-6. pp 154-156. London: Datapharm Publications Ltd, 1995.
2. Dental Practitioners Formulary 1994-96. p. D6. British National Formulary 1994-96. pp. 500-503. London: Pharmaceutical Press, 1994.
3. Dental Practitioners Formulary 1994-96. p. D6. British National Formulary 1994-96. pp. 500-503. London: Pharmaceutical Press, 1994.
4. Lignocaine. In Reynolds JEF (ed). Martindale: the extra, pharmacopoeia, 30th ed. pp 1010-1014. London: The Pharmaceutical Press, 1993.
5. Cawson R A, Curson I, Whittington D R. The hazards of dental local anaesthetics. Br Dent J 1983; 154: 253-258.
6. Minutes of the proceedings of the General Dental Council and Professional Conduct Committee 1995. p 2. London: GDC, 1995.
7. Bjorn H. Local analgesia, and local analgesics. pp 24-27. Watford: Astra Hewlett, 1968.
8. Taylor S E, Dorris R L. Modification of local anaesthetic toxicity by vasocontrictors. Anaesth Progress 1989; 36: 79-87.
9. Kaplam E L (ed). Cardiovascular disease in dental practice, p 27. Dallas: American Heart Association, 1986.
10. Pateronichelakis S. Circulating and respiratory effects of lignocaine administered into the rat maxillofacial circulation. J Oral Maxillofac Surg 1992; 50: 724-727.
11. Meechan J G, Blair G S. Clinical experience in oral surgery with two different automatic aspirating syringes. Int J Oral Maxillofac Surg 1989; 18: 87.
12. Tucker G T, Maher L E. Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokin 1979; 4: 241-278.
13. Barr J, Kirkpatrick N, Dick A, Leonard L, Hawsworth G, Noble D W. Effects of adrenaline and hyaluronidase on plasma concentrations of lignocaine and bupivacaine after peribulbar anaesthesia. Br J Anaesth 1995; 75: 692-697.
14. Meechan J G, Rood J P. Aspiration in dental local anaesthesia. Br Dent J 1992; 82: 40.
15. Rood J P. The pressure created by inferior alveolar injections. Br Dent J 1978; 144: 280-282.
16. Cannell H, Beckett A H. Peri-oral injections of local anaesthetic into defined sites. Br Dent J 1975; 139: 242-244.
17. Lilienthal B, Reynolds A K, Coffin R D, Ardeer F E. Comparative circulatory effects of adrenaline and noradrenaline during intra-osseous dental anaesthesia. Int J Clin Pharmacol 1975; 11: 331-339.
18. Cannell H, Cannon P D. Intraosseous injections of lignocaine local anaesthetics. Br Dent J 1976; 141: 48-50.
19. Salonen M, Forseel K, Scheinin M. Local dental anaesthesia with lignocaine and adrenaline. Int J Oral Maxillofac Surg 1988; 17: 392-394.
20. Foldes F F, Molby R, McNall P G, Koukal L R. Comparison of toxicity of intravenously given local anaesthetics in man. JAMA 1960; 172: 1494-1498.
21. Bromage P R, Robson J G. Concentrations of lignocaine in the blood after intravenous, intramuscular, epidural and endotracheal administration. Anaesthesia 1961; 16: 461-478.
22. Palve H, Kirvela O, Ohri H, Syvalahtl E, Kanto J. Maximum recommended doses of lignocaine are not toxic. Br J Anaesth 1995; 74: 704-705.
23. Gilma A G, Rale T W, Nies A S, Taylor P. Goodman und Gilman's the pharmacological basis of therapeutics, 8th ed. pp 1661-1668. NewYork: Pergamon, 1990.
24. Reynolds F. Local anaesthetic drugs. Clin Anaesthesiol 195; 2: 577-603.
25. Cannell H, Walters H, Beckettt A H, Saunders A. Circulating levels of lignocaine after peri-oral injections. Br Dent J 1975; 138: 87-93.
26. Goebel W M, Allen G, Randall F. Comparative circulatory serum levels of 2 per cent mepivacaine and 2 per cent lignocaine. Br Dent J1980; 148: 261-264.
27. Perovic J, Petrovic V, Obradovic O, Todorovic L. The influence of vasocontrictor in local anaesthetic solutions and injection sites on blood levels of lidocaine after intraoral application. Bull Gp int Rech sc stromat et Odent 1980;23: 113-117.
28. Rood J P, Cannell H. Plasma concentrations of lignocaine after peri-oral injections of two different concentrations. Pharm Ther Dent 1978; 3: 45-47
29. Cannell H. Comparative circulating serum levels. Br Dent J 1980; 149: 125.
30. Scott D B, Jebson P J, Vellami C W, Julian D G. Plasma levels of lignocaine after intramuscular injections. Lancet 1968; ii: 1209-1210.
31. Scott D B, Jebson P J, Braid D P, Orteagren B, Frisch P. Submucosal, subcutaneous and intermucostal injections of lignocaine. Br J Anaesth 1972; 44: 1040-1043.
32. Bonanno P C. Safe dosages of lignocaine for facial analgesia. J Craniofac Surg 1994: 5: 124-126.
33. Philips S, Hutchinson S E, Bayley P, Hollway T E. Adrenaline-induced hypotension in neurosurgery. Br J Anaesth 1993; 70: 687-688.
34. Lund P C, Cwik J C. A correlation of the differential penetration and the systemic toxicity of lignocaine, mepivacine and prilocaine in man. Acta. Anaesth Scand 1976; 23: 475-482.
35. Schwartz M L, Goucho B G, Narang R M et al. Blood levels of lidocaine following subcutaneous administration prior to cardiac catheterization. Am Heart J 1974; 88: 721-723.
36. Cannell H, Kerawala C, Webster K, Whelpton R. Are intraligamentary injections intravascular? Br Dent J 1993; 197: 281-284.
37. Aps C, Bell J A, Jenkins B S, Poole-Wilson P A, Reynolds F. Logical approach to lignocaine therapy. Br Med J 1975; 1: 13-15.
38. Prescott L F, Adepon-Yamoah K K, Talbot R G. Impaired lignocaine metabolism in patients with myocardial infarction and cardiac failure. Br Med J 1976; 1: 939-941.
39. Adepon-Yamoah, Nimmo J, Prescott L F. Gross impairment of hepatic drug metabolism in a patient with chronic liver disease. Br Med J 1974; 4: 387-388.
40. Leader. Doubts about lignocaine. Br Med J 1975; 5956: 473-474.
41. Evers H. Better local anaesthesia, can we improve the drugs? Lecture. Royal Society of Medicine March 6 1992.
42. Smith M, Wolfram W, Rose T. Toxicity - seizures in an infant caused by (or related to) oral viscous lidocaine use. J Emerg Med 1992; 10: 581-590.
43. Haglund J, Evers H. Local anaesthesia in dentistry. Malmo, Sweden: Trycken AB, 1972.
44. Michael S, Barker I, Henderson P, Griffiths R W, Reilly C S. Pharmacokinetics of lignocaine in children after infiltration for cleft palate surgery. Br J Anaesth 1992; 69: 577-579.